- Home
- ALRM vs TRVI Comparison
ALRM vs TRVI Comparison
Compare ALRM & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALRM | TRVI |
|---|---|---|
| Founded | 2000 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ALRM | TRVI |
|---|---|---|
| Price | $54.92 | $16.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $56.67 | $21.55 |
| AVG Volume (30 Days) | 311.5K | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.42 | ★ 31.91 |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $1,011,187,000.00 | N/A |
| Revenue This Year | $7.00 | N/A |
| Revenue Next Year | $4.53 | N/A |
| P/E Ratio | $58.96 | ★ N/A |
| Revenue Growth | ★ 7.59 | N/A |
| 52 Week Low | $41.49 | $7.65 |
| 52 Week High | $58.15 | $20.22 |
Technical Indicators
Market Signals| Indicator | ALRM | TRVI |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 39.30 |
| Support Level | $54.07 | $16.16 |
| Resistance Level | $58.03 | $19.30 |
| Average True Range (ATR) | 1.21 | 0.72 |
| MACD | -0.40 | -0.14 |
| Stochastic Oscillator | 9.12 | 17.52 |
Price Performance
Historical ComparisonAbout ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected device.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.